Matamala Morillo, Miguel ABelmonte Pintre, ZairaRodríguez González, MoisésSegado Arenas, Antonio2023-01-252023-01-252019http://hdl.handle.net/10668/14557Since their introduction, percutaneous techniques have been replacing conventional surgery as a first-line treatment for septal defects. Amplatzer devices were the first to be approved by the Food and Drug Administration, and their placement has become a standard procedure in pediatric cardiology. Bacterial endocarditis of intracardiac devices such as the Amplatzer septal occluder is very infrequent. We report a case of bacterial endocarditis in a pediatric patient with an Amplatzer device, who developed an infectious endocarditis six years after its placement and received conservative management with intravenous antibiotics, with satisfactory evolution.esAmplatzerconservative treatmentendocarditisseptal occluder deviceAnti-Bacterial AgentsChildConservative TreatmentEndocarditis, BacterialHumansMaleSeptal Occluder DeviceTreatment Outcome[Late onset endocarditis in Amplatzer carrier. Conservative management in a pediatric patient].Endocarditis tardía en un portador de un Amplatzer. Manejo conservador en un paciente pediátrico.research article31560497open access10.5546/aap.2019.e4891668-3501https://doi.org/10.5546/aap.2019.e489